OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
The Role of Immunotherapy in Pancreatic Cancer
Reetu Mukherji, Dipanjan Debnath, Marion L. Hartley, et al.
Current Oncology (2022) Vol. 29, Iss. 10, pp. 6864-6892
Open Access | Times Cited: 58
Reetu Mukherji, Dipanjan Debnath, Marion L. Hartley, et al.
Current Oncology (2022) Vol. 29, Iss. 10, pp. 6864-6892
Open Access | Times Cited: 58
Showing 1-25 of 58 citing articles:
Next-generation therapies for pancreatic cancer
Conor Buckley, Eileen M. O’Reilly
Expert Review of Gastroenterology & Hepatology (2024) Vol. 18, Iss. 1-3, pp. 55-72
Open Access | Times Cited: 15
Conor Buckley, Eileen M. O’Reilly
Expert Review of Gastroenterology & Hepatology (2024) Vol. 18, Iss. 1-3, pp. 55-72
Open Access | Times Cited: 15
Frontiers and future of immunotherapy for pancreatic cancer: from molecular mechanisms to clinical application
Rui Zheng, Xiaobin Liu, Yufu Zhang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 10
Rui Zheng, Xiaobin Liu, Yufu Zhang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 10
Overcoming therapy resistance in pancreatic cancer: New insights and future directions
Margarita Espona‐Fiedler, Cédric Patthey, Stina Lindblad, et al.
Biochemical Pharmacology (2024) Vol. 229, pp. 116492-116492
Open Access | Times Cited: 10
Margarita Espona‐Fiedler, Cédric Patthey, Stina Lindblad, et al.
Biochemical Pharmacology (2024) Vol. 229, pp. 116492-116492
Open Access | Times Cited: 10
Recent advances in sonodynamic therapy strategies for pancreatic cancer
Peng Cheng, Shuai Ming, Wei Cao, et al.
Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology (2024) Vol. 16, Iss. 1
Closed Access | Times Cited: 6
Peng Cheng, Shuai Ming, Wei Cao, et al.
Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology (2024) Vol. 16, Iss. 1
Closed Access | Times Cited: 6
Personalized Medicine in Pancreatic Cancer: The Promise of Biomarkers and Molecular Targeting with Dr. Michael J. Pishvaian
Viviana Cortiana, Rabab Hunaid Abbas, Harshal Chorya, et al.
Cancers (2024) Vol. 16, Iss. 13, pp. 2329-2329
Open Access | Times Cited: 6
Viviana Cortiana, Rabab Hunaid Abbas, Harshal Chorya, et al.
Cancers (2024) Vol. 16, Iss. 13, pp. 2329-2329
Open Access | Times Cited: 6
Different origin-derived exosomes and their clinical advantages in cancer therapy
Xiaoyan Jin, Jing Zhang, Yufu Zhang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 6
Xiaoyan Jin, Jing Zhang, Yufu Zhang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 6
Cancer Stem Cells in Pancreatic Ductal Adenocarcinoma
Roman Bubin, Romans Uljanovs, Ilze Štrumfa
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 8, pp. 7030-7030
Open Access | Times Cited: 15
Roman Bubin, Romans Uljanovs, Ilze Štrumfa
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 8, pp. 7030-7030
Open Access | Times Cited: 15
Genetic and other risk factors for pancreatic ductal adenocarcinoma (PDAC)
Michelle F. Jacobs, Elena M. Stoffel
Familial Cancer (2024) Vol. 23, Iss. 3, pp. 221-232
Closed Access | Times Cited: 4
Michelle F. Jacobs, Elena M. Stoffel
Familial Cancer (2024) Vol. 23, Iss. 3, pp. 221-232
Closed Access | Times Cited: 4
Advances of immune-checkpoint inhibition of CTLA-4 in pancreatic cancer
Ran Ni, Zhiming Hu, Ran Tao
Biomedicine & Pharmacotherapy (2024) Vol. 179, pp. 117430-117430
Open Access | Times Cited: 4
Ran Ni, Zhiming Hu, Ran Tao
Biomedicine & Pharmacotherapy (2024) Vol. 179, pp. 117430-117430
Open Access | Times Cited: 4
Current status and prospect of gut and oral microbiome in pancreatic cancer: Clinical and Translational Perspectives
Pengyu Li, Hanyu Zhang, Menghua Dai
Cancer Letters (2024) Vol. 604, pp. 217274-217274
Closed Access | Times Cited: 4
Pengyu Li, Hanyu Zhang, Menghua Dai
Cancer Letters (2024) Vol. 604, pp. 217274-217274
Closed Access | Times Cited: 4
The up-regulation of SPTAN1 expression in Pancreatic adenocarcinoma is associated with tumor immune invasion and poor clinical prognosis
Wei Guo, Lingyu Hu, Zhaofeng Gao, et al.
BMC Gastroenterology (2025) Vol. 25, Iss. 1
Open Access
Wei Guo, Lingyu Hu, Zhaofeng Gao, et al.
BMC Gastroenterology (2025) Vol. 25, Iss. 1
Open Access
The Current Role of Circulating Tumor DNA in the Management of Pancreatic Cancer
M.C. Cox, Dominic Vitello, Akhil Chawla
Journal of Gastrointestinal Cancer (2025) Vol. 56, Iss. 1
Closed Access
M.C. Cox, Dominic Vitello, Akhil Chawla
Journal of Gastrointestinal Cancer (2025) Vol. 56, Iss. 1
Closed Access
Molecular structure and mechanism of protein MSMB, TPPP3, SPI1: Construction of novel 4 pancreatic cancer-related protein signatures model based on machine learning
Zihan Ren, Wei Gao, Xin Li, et al.
International Journal of Biological Macromolecules (2025) Vol. 307, pp. 142075-142075
Closed Access
Zihan Ren, Wei Gao, Xin Li, et al.
International Journal of Biological Macromolecules (2025) Vol. 307, pp. 142075-142075
Closed Access
Research Progress of Ketogenic Diet for Pancreatic Cancer Treatment
志鹏 曲
Advances in Clinical Medicine (2025) Vol. 15, Iss. 03, pp. 1768-1773
Closed Access
志鹏 曲
Advances in Clinical Medicine (2025) Vol. 15, Iss. 03, pp. 1768-1773
Closed Access
Machine learning-based prognostic modelling of NK cells in PAAD for immunotherapy guidance
Li Li, Wu Zz, Wanxing Duan, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
Li Li, Wu Zz, Wanxing Duan, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
Inflammation, Immunosuppression, and Immunotherapy in Pancreatic Cancer—Where Are We Now?
Marta Fudalej, Katherine Krupa, Anna Badowska-Kozakiewicz, et al.
Cancers (2025) Vol. 17, Iss. 9, pp. 1484-1484
Open Access
Marta Fudalej, Katherine Krupa, Anna Badowska-Kozakiewicz, et al.
Cancers (2025) Vol. 17, Iss. 9, pp. 1484-1484
Open Access
Efficacy of LNP@2DG-DON liposomal nanoparticles in tumor inhibition and immune activation
Jianang Li, Jiale Feng, Runjie Liu, et al.
(2025)
Closed Access
Jianang Li, Jiale Feng, Runjie Liu, et al.
(2025)
Closed Access
The Importance of HHLA2 in Solid Tumors—A Review of the Literature
Agnieszka Kula, Dominika Koszewska, Anna Kot, et al.
Cells (2024) Vol. 13, Iss. 10, pp. 794-794
Open Access | Times Cited: 3
Agnieszka Kula, Dominika Koszewska, Anna Kot, et al.
Cells (2024) Vol. 13, Iss. 10, pp. 794-794
Open Access | Times Cited: 3
Multi-omic profiling of intraductal papillary neoplasms of the pancreas reveals distinct expression patterns and potential markers of progression
Yuefan Wang, Tung-Shing Mamie Lih, Jae W. Lee, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 3
Yuefan Wang, Tung-Shing Mamie Lih, Jae W. Lee, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 3
Machine learning based identification of an amino acid metabolism related signature for predicting prognosis and immune microenvironment in pancreatic cancer
Xiaohong Liu, Xing Wang, Jie Ren, et al.
BMC Cancer (2025) Vol. 25, Iss. 1
Open Access
Xiaohong Liu, Xing Wang, Jie Ren, et al.
BMC Cancer (2025) Vol. 25, Iss. 1
Open Access
Silicasomes in Oncology: From Conventional Chemotherapy to Combined Immunotherapy
Alicia Arroyo-Nogales, Guillermo Plaza-Palomo, Javier Gónzalez‐Larre, et al.
Molecules (2025) Vol. 30, Iss. 6, pp. 1257-1257
Open Access
Alicia Arroyo-Nogales, Guillermo Plaza-Palomo, Javier Gónzalez‐Larre, et al.
Molecules (2025) Vol. 30, Iss. 6, pp. 1257-1257
Open Access
Immune-Based Therapies in Pancreatic Cancer: a Systematic Review of Ongoing Clinical Trials (2020–2022)
Jen‐Yu Hung, Ritwick S Mynam, Monica Arun Patel, et al.
Journal of Gastrointestinal Cancer (2025) Vol. 56, Iss. 1
Closed Access
Jen‐Yu Hung, Ritwick S Mynam, Monica Arun Patel, et al.
Journal of Gastrointestinal Cancer (2025) Vol. 56, Iss. 1
Closed Access
Hepatic myofibroblasts exert immunosuppressive effects independent of the immune checkpoint regulator PD-L1 in liver metastasis of pancreatic ductal adenocarcinoma
Silje Beckinger, Tina Daunke, Leon Aldag, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 8
Silje Beckinger, Tina Daunke, Leon Aldag, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 8
NUDT21 interacts with NDUFS2 to activate the PI3K/AKT pathway and promotes pancreatic cancer pathogenesis
Xiao-Dong Huang, Yongwei Chen, Tian Lv, et al.
Journal of Cancer Research and Clinical Oncology (2024) Vol. 150, Iss. 1
Open Access | Times Cited: 3
Xiao-Dong Huang, Yongwei Chen, Tian Lv, et al.
Journal of Cancer Research and Clinical Oncology (2024) Vol. 150, Iss. 1
Open Access | Times Cited: 3
PABPC1 silencing inhibits pancreatic cancer cell proliferation and EMT, and induces apoptosis via PI3K/AKT pathway
Changren Zhu, Cuimei Wang, Xiaodong Wang, et al.
Cytotechnology (2024) Vol. 76, Iss. 3, pp. 351-361
Closed Access | Times Cited: 3
Changren Zhu, Cuimei Wang, Xiaodong Wang, et al.
Cytotechnology (2024) Vol. 76, Iss. 3, pp. 351-361
Closed Access | Times Cited: 3
